Dr Aathavan Loganayagam, Consultant Gastroenterologist

Dr Aathavan Loganayagam

Consultant Gastroenterologist

Dr Aathavan Loganayagam MBBS BSc MRCP

Consultant Gastroenterologist

MBBS BSc MRCP

Dr Aathavan Loganayagam

Consultant Gastroenterologist MBBS BSc MRCP

MBBS BSc MRCP

Areas of expertise

  • Bowel cancer
  • Upper GI endoscopy
  • Gastroscopy
  • Indigestion (dyspepsia)
  • Inflammatory bowel disease (IBD)

Recommendations for Dr Loganayagam

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byMr Rajab Kerwat, Consultant General Surgeon

    A fantastic gastroenterologist with a special interested in inflammatory bowel disease; he is a very dedicated physician gastroenterologist and an excellent colleague.

  • byMr Rajab Kerwat, Consultant General Surgeon

    A fantastic gastroenterologist with a special interested in inflammatory bowel disease; he is a very dedicated physician gastroenterologist and an excellent colleague.

  • Address

    • HCA UK at The Shard

      The Shard, 32 St Thomas Street, London, SE1 9BS

    • London Bridge Hospital

      27 Tooley Street, London, SE1 2PR

    About Dr Aathavan Loganayagam

    GMC number: 4742373

    Year qualified: 2000

    Place of primary qualification: University of London

    Dr Aathavan Loganayagam is a highly skilled gastroenterologist based at Queen Elizabeth Hospital, Woolwich. He completed his medical training at Guy's, King's, and St. Thomas' medical schools, followed by specialty training in gastroenterology and general internal medicine through the esteemed South London training programme.

    Dr Loganayagam further honed his expertise during a two-year postgraduate fellowship at Guy's and St Thomas' Hospitals, London, focusing on research and endoscopy. His research interests include pharmacogenetics, inflammatory bowel disease, and gastrointestinal malignancy. His outstanding contributions to research have earned him several awards, including the prestigious NHS Innovation London Award.

    With numerous publications in peer-reviewed journals, Dr Loganayagam is a recognised authority in gastroenterology. He is particularly noted for his work in personalised medicine and the use of novel therapeutic agents to treat complex inflammatory bowel disease. As the lead clinician for endoscopy at Queen Elizabeth Hospital, he oversees both diagnostic and advanced therapeutic endoscopy procedures.

    Dr Loganayagam's clinical expertise encompasses a wide range of procedures and conditions. He is proficient in polypectomy, endoscopic mucosal resection (EMR), breath testing, oesophageal manometry, therapeutic endoscopy, colonoscopy, and upper GI endoscopy. He is also experienced in the diagnosis and treatment of gastrointestinal cancers, including bowel/colorectal, pancreatic, stomach/gastric, and oesophageal cancers. Additionally, he treats conditions such as anaemia, bacterial overgrowth/intestinal dysbiosis, and food intolerances/allergies.

    Known for his approachable nature and excellent communication skills, Dr Loganayagam is dedicated to ensuring that his patients are fully informed and involved in their care. He takes pride in providing personalised and compassionate medical care to all his patients.

    Dr Loganayagam has been serving at Queen Elizabeth Hospital since his appointment and continues to contribute significantly to the field of gastroenterology through both his clinical practice and ongoing research.

    Areas of expertise

    • Inflammatory bowel disease
    • Diagnostic and therapeutic endoscopy
    • Diagnosis and screening of gastrointestinal cancers
    • Hepatology
    • Irritable bowel syndrome/functional bowel disease
    • Dyspepsia/reflux
    • Nutrition
    • Coeliac disease

    Professional memberships

    Royal College of Physicians
    General Medical Council

    Articles by Dr Aathavan Loganayagam

    Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the united kingdom